Antitsa Stoycheva

Preclinical Characteristics of the Hepatitis C Virus NS3/4A Protease Inhibitor ITMN-191 (R7227)

Scott D. Seiwert, Steven W. Andrews, Yutong Jiang et al. · Antimicrobial Agents and Chemotherapy · 2008 · 173 citations · Full text

Biochemistry, Viral Hepatitis, Medicine +14

The Substitutions L50F, E166A, and L167F in SARS-CoV-2 3CLpro Are Selected by a Protease Inhibitor <i>In Vitro</i> and Confer Resistance To Nirmatrelvir

Dirk Jochmans, Kim Donckers, Antitsa Stoycheva et al. · mBio · 2023 · 163 citations · Full text

Molecular Basis for the Selective Inhibition of Respiratory Syncytial Virus RNA Polymerase by 2'-Fluoro-4'-Chloromethyl-Cytidine Triphosphate

Jérôme Deval, Jin Tae Hong, Guangyi Wang et al. · PLoS Pathogens · 2015 · 90 citations · Full text

Selective Inhibition, Viral Replication, Molecular Virology +15

Stripe Melting in a Two-Dimensional System with Competing Interactions

Antitsa Stoycheva, Sherwin J. Singer · Physical Review Letters · 2000 · 86 citations

Materials Science, Engineering, Physics +12

Regulation of gene transcription by thyroid hormone receptor β agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH)

Xuan G. Luong, Sarah Stevens, Andreas Jekle et al. · PLoS ONE · 2020 · 66 citations · Full text